Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Drug reduces heart attack risk in angina patients

  • Comment

The new drug, Ivabradine, that slows down heart rate has reduced the risk of heart attacks in angina patients by 42%, doctors say.

According to a new study, Ivabradine has led to a 73% risk reduction in patients with a heart rate of 70 beats-per-minute or more.

Angina, a feeling of tightness or pain in the chest caused by not enough blood reaching the heart, may presage a heart attack.

As many as two million people in the UK suffer from angina. Ivabradine is licensed in the UK for angina patients who cannot be given beta blockers, medicines used to treat a range of heart conditions.

The findings of the study, that involved around 11,000 patients, were presented at the European Society of Cardiology’s annual meeting in Barcelona, Spain.

The trial’s lead investigator Professor Kim Fox, consultant cardiologist at the Royal Brompton Hospital, London, said: ‘Heart and circulatory disease is the biggest killer in the UK. To stop this, we need to identify new ways to reduce these deaths. The latest findings reinforce that ivabradine may reduce the number of heart attacks in people with angina, especially in those with a faster heart rate.’

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs